MRS studies clearly failed to demonstrate the presence of brain and skeletal muscle oxidative metabolism in WS patients at different stages of disease, in contrast with previous findings in patients with mitochondrial optic neuropathies such as LHON and DOA (OPA1 mutations)42,43. This evidence concerns the gene OPA1 and Leber hereditary optic neuropathy.